Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000143 · ClinicalTrials.gov registry record · Phase 3
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
A Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 61
- Enrollment target
NCT00000143 is a Phase 3 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 61 participants.
The verdict
NCT00000143, a Phase 3 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 61 participants
- Enrollment target
Study Summary
To compare the newest CMV retinitis drug, cidofovir, with a regimen of the ganciclovir intraocular device plus oral ganciclovir with respect to efficacy in preventing vision loss. To compare a treatment regimen that incorporates highly active local therapy (ganciclovir device) with a treatment regimen that does not.
Interventions
- DEVICE Ganciclovir implant and oral ganciclovir
- DRUG Cidofovir intravenous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 1997-05 |
| Est. Completion | 2000-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000143
The ClinicalTrials.gov registry entry for NCT00000143 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ganciclovir implant and oral ganciclovir is the first listed.
NCT00000143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000143 about?
NCT00000143 is a clinical study titled "Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)". To compare the newest CMV retinitis drug, cidofovir, with a regimen of the ganciclovir intraocular device plus oral ganciclovir with respect to efficacy in preventing vision loss. To compare a treatment regimen that incorporates highly active local therapy (ganciclovir device) with a treatment regi...
What is the current status of trial NCT00000143?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 61 participants. The study started on 1997-05. Estimated completion is 2000-06.
What interventions are being tested in trial NCT00000143?
The interventions under investigation include: Ganciclovir implant and oral ganciclovir (DEVICE), Cidofovir intravenous (DRUG).
Who is sponsoring clinical trial NCT00000143?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.